BioNTech SE (BNTX) Raw Materials (2018 - 2021)

BioNTech SE has reported Raw Materials for 4 years, with the latest figure at $284.0 million in Q4 2021.

• Quarterly Raw Materials rose 437.78% year-over-year to $284.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $284.0 million (up 437.78% YoY) and the FY2021 annual result came in at $293.8 million, up 480.93% from the prior year.
• Raw Materials advanced to $284.0 million in Q4 2021 per BNTX's latest filing, from $52.8 million in the prior quarter.
• Over five years, Raw Materials peaked at $284.0 million in Q4 2021 and troughed at $5.1 million in Q4 2018.
• A 4-year average of $87.8 million and a median of $30.9 million in 2020 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2019 and 2020: Raw Materials jumped 77.72% in 2019, then jumped 481.86% in 2020.
• Over 4 years, Raw Materials stood at $5.1 million in 2018, then surged by 77.72% to $9.1 million in 2019, then surged by 481.86% to $52.8 million in 2020, then soared by 437.78% to $284.0 million in 2021.
• According to Business Quant data, Raw Materials over the past three periods registered $284.0 million, $52.8 million, and $9.1 million for Q4 2021, Q4 2020, and Q4 2019 respectively.